Literature DB >> 8626432

Expression and function of ryanodine receptors in nonexcitable cells.

D L Bennett1, T R Cheek, M J Berridge, H De Smedt, J B Parys, L Missiaen, M D Bootman.   

Abstract

We have used reverse transcriptase-polymerase chain reaction to investigate the expression of ryanodine receptors in several excitable and nonexcitable cell types. Consistent with previous reports, we detected ryanodine receptor expression in brain, heart, and skeletal muscle. In addition, we detected ryanodine receptor expression in various other excitable cells including PC 12 and A7r5 cells. Several muscle cell lines (BC3H1, C2C12, L6, and Sol8) weakly expressed ryanodine receptor when undifferentiated but strongly expressed type 1 and type 3 ryanodine receptor isoforms when differentiated into a muscle phenotype. Only 2 (HeLa and LLC-PK1 cells) out of 11 nonexcitable cell types examined expressed ryanodine receptors. Expression of ryanodine receptors at the protein level in these cells was confirmed using [3H]ryanodine binding. We also investigated the function of ryanodine receptors in Ca2+ signaling in HeLa cells using single-cell Fura-2 imaging. Neither caffeine nor ryanodine caused a detectable elevation of cytoplasmic Ca2+ in single HeLa cells. However, ryanodine caused a significant decrease in the amplitude of Ca 2+ signals evoked by repetitive stimulation with ATP. These studies show that ryanodine receptors are expressed in some nonexcitable cell types and furthermore suggest that the ryanodine receptors may be involved in a subtle regulation of intracellular Ca2+ responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626432     DOI: 10.1074/jbc.271.11.6356

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Lysophosphatidic acid-mediated Ca2+ mobilization in human SH-SY5Y neuroblastoma cells is independent of phosphoinositide signalling, but dependent on sphingosine kinase activation.

Authors:  K W Young; R A Challiss; S R Nahorski; J J MacKrill
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Triad proteins and intracellular Ca2+ transients during development of human skeletal muscle cells in aneural and innervated cultures.

Authors:  H Tanaka; T Furuya; N Kameda; T Kobayashi; H Mizusawa
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

3.  Reversible block of the calcium release channel/ryanodine receptor by protamine, a heparin antidote.

Authors:  P Koulen; B E Ehrlich
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

4.  Nuclear and cytosolic calcium are regulated independently.

Authors:  M F Leite; E C Thrower; W Echevarria; P Koulen; K Hirata; A M Bennett; B E Ehrlich; M H Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

5.  Sparks and puffs in oligodendrocyte progenitors: cross talk between ryanodine receptors and inositol trisphosphate receptors.

Authors:  L L Haak; L S Song; T F Molinski; I N Pessah; H Cheng; J T Russell
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

6.  Activation of store-operated I(CRAC) by hydrogen peroxide.

Authors:  Morten Grupe; George Myers; Reinhold Penner; Andrea Fleig
Journal:  Cell Calcium       Date:  2010-06-19       Impact factor: 6.817

7.  Store-operated Ca2+ Entry Modulates the Expression of Enamel Genes.

Authors:  M K Nurbaeva; M Eckstein; M L Snead; S Feske; R S Lacruz
Journal:  J Dent Res       Date:  2015-07-31       Impact factor: 6.116

8.  Evidence that the cADPR signalling pathway controls calcium-mediated microneme secretion in Toxoplasma gondii.

Authors:  Eduardo N Chini; Kisaburo Nagamune; Dawn M Wetzel; L David Sibley
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

9.  Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification.

Authors:  Lina Zhang; Yuexin Liu; Fengju Song; Hong Zheng; Limei Hu; Hong Lu; Peifang Liu; Xishan Hao; Wei Zhang; Kexin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-02       Impact factor: 11.205

10.  CCDI: a new ligand that modulates mammalian type 1 ryanodine receptor (RyR1).

Authors:  Chengju Tian; Chun Hong Shao; Christina Padanilam; Edward Ezell; Jaipaul Singh; Shelby Kutty; Keshore R Bidasee
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.